Improving Diabetes Research: Moving Beyond Animal Models. Charu Chandrasekera, Ph.D. Anne Bunner, Ph.D.
|
|
- Hector Newton
- 6 years ago
- Views:
Transcription
1 Improving Diabetes Research: Moving Beyond Animal Models Charu Chandrasekera, Ph.D. Anne Bunner, Ph.D. July 19, 2014
2 From Bench-to-Bedside Sulfonylurea Biguanide Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist
3 From Bench-to-Bedside Januvia DPP- 4 GLP-1 Victoza GLP-1 PI3K Akt Rap Erk1/2 Glyburide Insulin Secretion Pancreatic β-cell
4 Type 2 Diabetes Research 1. Animal models of human type 2 diabetes 2. Limitations of animal models 3. Humanizing type 2 diabetes research
5 1. Animal Models of Type 2 Diabetes in Basic Research
6 Animal Models of Diabetes
7 Deciphering Diabetes The Problem Research Questions: - How? - What? - Why? - Why not? - When? The Solution! - Where? - What else?
8 Rodent Models this is how we do it
9 Rodent Models: Surgical Induction Non-obese diabetic model Partial (10 90%) or Complete pancreatectomy Extent of pancreatectomy governs severity of disease
10 Rodent Models: Chemical Induction Streptozotocin Glucose GLUT2 Irreversible β-cell cytotoxicity Non-obese model Dosage governs severity of disease Alloxan
11 Rodent Models: Dietary Modification Cafeteria Diet
12 Rodent Models: Dietary Modification Pre-Defined High-Fat Diets 30% 20% Fat content 50% 40% 70% 60% Fat types Olive oil Butter Coconut oil Fish oil Lard Beef tallow Vegetable shortening Obese diabetic models Diet type influences disease phenotype Other Components High Sucrose High Fructose Protein Micronutrients
13 Rodent Models: Genetic Models Obese diabetic models Naturally occurring Spontaneous Genetic Models Leptin and leptin receptor mutations e.g., ob/ob mouse, db/db mouse, Zucker fatty rat, Zucker diabetic fatty rat
14 Rodent Models: Genetic Models Knock-out Genetically Engineered Models Obese & non-obese Disease severity depends on genetic alteration Knock-in Transgenic
15 Rodent Models of Diabetes > 50 publications / month Chandrasekera et al. ALTEX 2014; 31: ob/ob db/db ZDF Other Rats Spontaneously Chemical Transgenic Diabetic Dietary Surgical
16 2. Limitations of Animal Models
17 Deciphering Diabetes In order for a rodent model to have relevance to human diabetes, it should display causes natural history pathophysiology manifestations complications drug responses in a manner similar to what is observed in humans.
18 Deciphering Diabetes Human T2DM = multifactorial & complex Type 2 Diabetes
19 Of Rodents and Men 1. Experimental Limitations 2. Biological Limitations 3. Species Differences
20 1. Experimental Limitations: Surgical Induction Sudden pancreatic loss Extent governs disease severity e.g., 80% resection gives mild hyperglycemia β-cell regeneration & full recovery Loss of counter-regulation e.g., glucagon Chandrasekera et al. ALTEX 2014; 31:157-76
21 1. Experimental Limitations: Chemical Induction Dosage dependence Streptozotocin Extrapancreatic cytotoxic effects e.g., disruption of the HPG axis Human β-cells resistant to streptozotocin in rodents, enter cells via GLUT2 GLUT1 GLUT3 Chandrasekera et al. ALTEX 2014; 31:157-76
22 1. Experimental Limitations: Dietary Induction Diet type Diet components Control diet Age of onset of diet Duration of diet Lai et al. Nutr Diabetes, 2014
23 1. Experimental Limitations: Genetic Induction Leptin mutations rare in humans Wang et al. Curr Diab Rev. 2014; 10: Single-gene effect Exaggerated & compensatory effects Developmental defects Bunner et al. World J Diab. 2014; 5:
24 2. Biological Limitations Age young adult old Sex No disease phenotype Prominent disease phenotype Strain C57BL/6J, AKR/J, FVB/N, 129SeVe
25 2. Biological Limitations Heterogeneity among strains 60% weight gain Heterogeneity within one strain 30% weight gain 10% weight gain Control High Fat Diet Weight gain Plasma glucose Plasma insulin Serum lipid Glucose tolerance
26 2. Biological Limitations Health of laboratory animals is poor by human standards Control laboratory rodents are metabolically morbid: why it matters Obese Insulin resistant Hypertesive On a trajectory to premature death profound differences in experimental outcome confound data interpretation and outcomes of human studies Martin et al. PNAS 2010; 107:
27 Chandrasekera et al. ALTEX 2014; 31: Species Differences
28 3. Species Differences
29 3. Species Differences α δ β
30 3. Species Differences
31 Critiques of Rodent Models Of rodents and men: species specificity of glucose regulation and type 2 diabetes research. Chandrasekera et al. ALTEX 2014; 31(2): Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Wang et al. Curr Diab Rev. 2014; 10(2): Knockout mouse models of insuling signaling: relevance past and future. Bunner et al. World J Diabetes. 2014; 5(2): You are what you eat, or are you? The challenges of translating high-fatfed rodents to human obesity and type 2 diabetes. Lai et al. Accepted for publication in Nutrition & Diabetes, 2014 From animal models to clinical practicality: lessons learned from current translational progress of diabetic peripheral neuropathy. Li et al. In: Souayah N, ed. Peripheral Neuropathy - A New Insight into the Mechanism, Evaluation and Management of a Complex Disorder. New York, NY 2013.
32 Limitations of Rodent Models: The Case of ZnT8 Zn 2+ insulin secretory granules ZnT8 zinc transporter Genetic study in a small French population identified novel risk loci for T2D: Sladek et al. Nature 2007; 445: insulin secretory granules
33 Limitations of Rodent Models: The Case of ZnT8 ZnT8 zinc transporter ZnT8 Gene Deletion ZnT8 Knockout
34 Limitations of Rodent Models: The Case of ZnT8
35 Limitations of Rodent Models: The Case of ZnT8 ZnT8 Knockout Variability Age Sex Strain Weight gain Blood glucose Plasma insulin Glucose tolerance Insulin secretion Diet Disease Severity No Change Significant Increase Marked Reduction
36 Limitations of Rodent Models: The Case of ZnT8 Pound et al. PLoS One 2012; 7:e40972
37 Limitations of Rodent Models: The Case of ZnT8 intriguing differences between the phenotypes of the animal models 150,000 humans with protein-truncating mutations loss of ZnT8 increased disease risk loss of ZnT8 reduced disease risk Rutter GA. Islets 2010; 2: Flannnick et al. Nat Genet 2014; 46:
38 Limitations of Rodent Models causes natural history pathophysiology manifestations complications drug responses
39 Deciphering Diabetes NOT The Solution! The Problem
40 3. Human-based Methods
41
42 Human Data Modeling complex interactions in silico Algorithms for pancreas function were used to develop a closedloop insulin pump. Kovatchev B, et al. (2009) J Diabetes Sci Technol 3, Kovatchev B, et al. (2010) J Diabetes Sci Technol 4,
43 Genome-Wide Association Studies Patients Nonpatients Disease-specific markers Patient DNA Compare differences to discover genetic markers associated with diseases Non-patient DNA Non-disease markers
44 Human Populations Population-based studies reveal genetic and environmental factors.
45 Odds Ratio Dietary factors AHS-2 study 41,000 people asked about diets and health Followed for 2 years Diabetes Incidence * * * * 95% CI shown Tonstad S, et al. (2013) Nutr Metab Cardiovasc Dis 23,
46 Human Beings Safe and ethical PET and functional MRI can be used to monitor glucose and insulin in volunteers. Bertoldo A, et al. (2006) Diabetes 55, Tesfaye and Selvarajah (2012) Diab/Metab Res Rev 28, S8-S14. Kullmann, et al. (2012) Human Brain Mapping 33,
47 GLP-1 and insulin secretion Glucagon-like peptide 1 (GLP-1) is a peptide important for normal glucose tolerance Victoza is a GLP-1 agonist Does GLP-1 work the same way in diabetes patients as in healthy volunteers? Drug that temporarily blocks GLP-1 activity drug Healthy volunteers drug Type 2 Diabetes patients GLP-1 GLP-1 Insulin secretion Insulin secretion Salehi M, et al. (2010) Diabetes 59,
48 Human Organs Microfluidic systems mimic architecture of tissues and organs Commercially available liver cells
49 Human Tissues Tissues from: cadavers surgical patients
50 Human islets for drug screening Cultured human islets from cadavers Islets produced insulin in response to glucose Islets exposed to 1,280 compounds Used automated technology to detect changes in insulin secretion Functional cultured islets indicated by white arrowheads Walpita D, et al. (2012) J Biomol Screen 17,
51 Human islets for drug screening Functional cultured islets indicated by white arrowheads Walpita D, et al. (2012) J Biomol Screen 17,
52 Human Cells A human pancreatic β- cell line is now available for insulin secretion studies. Ravassard P, et al. (2011) J Clin Invest 121,
53 Inflammation and insulin resistance in human skeletal muscle How does inflammation contribute to insulin resistance? What genes are involved? Researchers used muscle cells from volunteers Turned off a certain gene in some samples to observe differences in response Stimulus Signaling protein Austin RL, et al. (2008) Diabetes 57, Insulin resistance Bouzakri K and Zierath JR (2007) J Biol Chem 282,
54 Many options for human studies Human studies are: Reliable Relevant Practical
55 Thank you for your attention! Questions?
You are what you eat, or are you? The challenges of translating high-fat-fed rodents to human obesity and diabetes
OPEN Citation: Nutrition & Diabetes (2014) 4, e135; doi:10.1038/nutd.2014.30 2014 Macmillan Publishers Limited All rights reserved 2044-4052/14 www.nature.com/nutd REVIEW You are what you eat, or are you?
More informationFRIDAY, JUNE 21. Epidemiology/ Genetics. Symposium The Big Picture Genetic Architecture of Diabetes Room S 103 B
Registration Hours: 9:00 a.m. 6:30 p.m. Shop Store Hours: 9:00 a.m. 6:30 p.m. FRIDAY, JUNE 21 Noon 12:40 p.m. Meet the Expert Sessions 12:50 p.m. 1:30 p.m. Meet the Expert Sessions 2:00 p.m. 4:00 p.m.
More informationThe Mediterranean Diet: HOW and WHY It Works So Well for T2DM
The Mediterranean Diet: HOW and WHY It Works So Well for T2DM Susan L. Barlow, RD, CDE. Objectives 1. Discuss the effects of meal size on GLP-1 concentrations. 2. Compare and contrast the specific effects
More informationGlucose Homeostasis. Liver. Glucose. Muscle, Fat. Pancreatic Islet. Glucose utilization. Glucose production, storage Insulin Glucagon
Glucose Homeostasis Liver Glucose Glucose utilization Glucose production, storage Insulin Glucagon Muscle, Fat Pancreatic Islet Classification of Diabetes Type 1 diabetes Type 2 diabetes Other types of
More informationDefinition of diabetes mellitus
Diabetes mellitus II - III First and second type of diabetes mellitus Lecture from pathological physiology Oliver Rácz, 2011-2018 Definition of diabetes mellitus Diabetes mellitus is a group of metabolic
More informationDiscussion & Conclusion
Discussion & Conclusion 7. Discussion DPP-4 inhibitors augment the effects of incretin hormones by prolonging their half-life and represent a new therapeutic approach for the treatment of type 2 diabetes
More informationTherapeutic strategy to reduce Glucagon secretion
Clinical focus on glucagon: α-cell as a companion of β-cell Therapeutic strategy to reduce Glucagon secretion Sunghwan Suh Dong-A University Conflict of interest disclosure None Committee of Scientific
More informationNIH Public Access Author Manuscript Diabetologia. Author manuscript; available in PMC 2014 February 01.
NIH Public Access Author Manuscript Published in final edited form as: Diabetologia. 2013 February ; 56(2): 231 233. doi:10.1007/s00125-012-2788-6. Lipotoxicity impairs incretin signalling V. Poitout 1,2
More informationDiabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs
Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,
More informationHistory of Investigation
Acini - Pancreatic juice (1º) (2º) Secretions- neuronal and hormonal mechanisms 1) Secretin - bicarbonate rich 2) Cholecystokinin - enzyme rich Islets of Langerhans (contain 4 cell types) Alpha cells (α)-
More informationInflammation & Type 2 Diabetes Prof. Marc Y. Donath
Inflammation & Type 2 Diabetes 1, MD Chief Endocrinology, Diabetes & Metabolism University Hospital Basel Petersgraben 4 CH-431 Basel, Switzerland MDonath@uhbs.ch Innate immunity as a sensor of metabolic
More informationPersonalized therapeutics in diabetes
Personalized therapeutics in diabetes Leen M. t Hart Molecular Cell Biology & Molecular Epidemiology Leiden University Medical Center Epidemiology & Biostatistics VU University Medical Center Diabetes
More informationGLP 1 agonists Winning the Losing Battle. Dr Bernard SAMIA. KCS Congress: Impact through collaboration
GLP 1 agonists Winning the Losing Battle Dr Bernard SAMIA KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web: www.kenyacardiacs.org Disclosures I have
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationPathogenesis of Diabetes Mellitus
Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia
More informationIndustrialized Food Components and Obesity Risk. Kylie Kavanagh, VMS MS MPH Department of Pathology
Industrialized Food Components and Obesity Risk Kylie Kavanagh, VMS MS MPH Department of Pathology Overview Role of science in policy development Components versus calories Past lessons (trans fat) Present
More informationBIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity
BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising
More informationDiabetes: What is the scope of the problem?
Diabetes: What is the scope of the problem? Elizabeth R. Seaquist MD Division of Endocrinology and Diabetes Department of Medicine Director, General Clinical Research Center Pennock Family Chair in Diabetes
More informationTreating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric
Treating Type 2 Diabetes with Bariatric Surgery Number (in Millions) of Persons with Diagnosed Diabetes, United States, 198 25 The number of Americans with diabetes increased from 5.6 to 15.8 million Guilherme
More information6/1/2018. Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE
Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE 1 2 3 Sulfonylureas Glipizide Glyburide Glimeperide 4 Metformin Gold
More informationObesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes
Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes Genetics, environment, and lifestyle (obesity, inactivity, poor diet) Impaired fasting glucose Decreased β-cell
More informationMy Journey in Endocrinology. Samuel Cataland M.D
My Journey in Endocrinology Samuel Cataland M.D. 1968-2015 Drs Berson M.D. Yalow phd Insulin Radioimmunoassay Nobel Prize Physiology or Medicine 1977 Rosalyn Yalow: Radioimmunoassay Technology Andrew Schally
More informationA Central Role of MG53 in Metabolic Syndrome. and Type-2 Diabetes
A Central Role of MG53 in Metabolic Syndrome and Type-2 Diabetes Yan Zhang, Chunmei Cao, Rui-Ping Xiao Institute of Molecular Medicine (IMM) Peking University, Beijing, China Accelerated Aging in China
More informationDEVELOPMENT OF NEW ANIMAL MODELS FOR TYPE 2 DIABETES MELLITUS AND PHARMACOLOGICAL SCREENING
2) LITERATURE REVIEW 1. Srinivasan et al., (2005) developed a new rat model that replicates the natural history and metabolic characteristics of human type 2 diabetes and is also suitable for pharmacological
More informationGLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK
GLP-1 agonists Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What do GLP-1 agonists do? Physiology of postprandial glucose regulation Meal ❶ ❷ Insulin Rising plasma
More informationRhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain
Rhonda Eustice, PharmD, CDE Will Power lasts about two weeks and is soluble in alcohol. Mark Twain Diabetes Management: The Three Legged Stool Diet Medication Exercise Objectives Know the treatment goals
More informationThe uses of animal models in the evaluation of functional foods
The uses of animal models in the evaluation of functional foods Jane Chao, Ph.D. Taipei Medical University School of Nutrition and Health Sciences November 30, 2006 1 Content Assessments for health claims
More informationNew therapeutic targets for T2DM
New therapeutic targets for T2DM Targeting inflammation: NF- B, salsalate Gwanpyo Koh Department of Internal Medicine Jeju National University School of Medicine Introduction Obesity is occurring at epidemic
More informationDiabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute
Diabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute Disclosure Information Melena D. Bellin Disclosure of Relevant
More informationEndo 2 SLO Practice (online) Page 1 of 7
Endo 2 SLO Practice (online) Page 1 of 7 1. A long- acting insulin, like Lantus is for? A. When the next meal is within 30-60 minutes of the injection B. Over night use or for ½ of the day often combined
More informationPractical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010
Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE Robert R. Henry, MD Authors and Disclosures CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010 Introduction Type 2 diabetes
More informationType 2 Diabetes and Cancer: Is there a link?
Type 2 Diabetes and Cancer: Is there a link? Sonali Thosani, MD Assistant Professor Department of Endocrine Neoplasia & Hormonal Disorders MD Anderson Cancer Center No relevant financial disclosures Objectives
More informationAnimal Models of Diabetes and Insulin Resistance. Masakazu Shiota, D.V.M., Ph.D An Organ System.. Course. July 18, 2012
Animal Models of Diabetes and Insulin Resistance Masakazu Shiota, D.V.M., Ph.D An Organ System.. Course. July 18, 2012 What is different between human and animals? mouse rat dog human What is different
More informationLipids Carbohydrate Protein. Fatty Acids Glycerol. Mono/di-saccarides. Aminoacids. Fat Liver Muscle. Triglycerides Glycogen Protein
Lipids Carbohydrate Protein Fatty Acids Glycerol Mono/di-saccarides Fat Liver Muscle Aminoacids Triglycerides Glycogen Protein Microvascular Macrovascular Diabetes-specific Diabetes-enhanced HbA1c 5.7(6.0)
More informationa. What is the stimulus? Consuming a large pumpkin spice muffin and caramel macchiato.
: Homeostasis and Macromolecules Unit Study Guide Homeostasis 1. Define homeostasis and give an example. Homeostasis is the ability of the body to maintain relatively constant internal physical and chemical
More informationSubject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119
Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationType 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM
Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes
More informationSpontaneously Diabetic Torii Lepr fa (SDT Fatty) Rat: A Novel Model of Obese Type 2 Diabetes
30 The Open Diabetes Journal, 2011, 4, 30-36 Open Access Spontaneously Diabetic Torii Lepr fa (SDT Fatty) Rat: A Novel Model of Obese Type 2 Diabetes Sumiaki Fukuda, Katsuhiro Miyajima, Tomohiko Sasase
More informationObesity in aging: Hormonal contribution
Obesity in aging: Hormonal contribution Hormonal issues in obesity and aging Hormonal role in regulation of energy balance Genetic component in hormonal regulation Life style contribution to hormonal changes
More informationDIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents
overview of pharmacologic agents used in the management of DIABETES Kyle Roberts, Pharm.D. PGY-1 Pharmacy Resident Saint Alphonsus RMC 1. List the different classes of diabetes medications, including the
More informationNASH Bench to Bedside
NASH Bench to Bedside October 2006 Anna Mae Diehl, M.D. Gastroenterology Division Duke University NonAlcoholic Fatty Liver Disease Common ~1/4-1/3 1/3 US adults Outcome highly variable Course indolent
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Single Technology Appraisal Canagliflozin in combination therapy for Final scope Remit/appraisal objective To appraise the clinical and cost effectiveness
More informationROLE OF TASTE IN METABOLIC CONTROL OF TYPE 1 DIABETES MELLITUS
Progress report ROLE OF TASTE IN METABOLIC CONTROL OF TYPE 1 DIABETES MELLITUS Dr Gianluca Tornese, MD, PhD Background The sense of taste is one of the main factors that determine the choice of food and
More information28/04/51. Introduction. Insulin signaling effects on memory and mood. Is accelerated brain aging a consequence of diabetes? chronic hyperglycemia
Introduction Insulin signaling effects on memory and mood (Review) Diabetes mellitus is a chronic disease resulting from defects in insulin secretion, insulin action, or both Long-term diabetes Lawrence
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationEffect of macronutrients and mixed meals on incretin hormone secretion and islet cell function
Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Background. Following meal ingestion, several hormones are released from the gastrointestinal tract. Some
More informationOverview. o Limitations o Normal regulation of blood glucose o Definition o Symptoms o Clinical forms o Pathophysiology o Treatment.
Pål R. Njølstad MD PhD KG Jebsen Center for Diabetes Research University of Bergen, Norway Depertment of Pediatrics Haukeland University Hospital Broad Institute of Harvard & MIT Cambridge, MA, USA Hypoglycemia
More informationIDF Regions and global projections of the number of people with diabetes (20-79 years), 2013 and Diabetes Atlas -sixth Edition: IDF 2013
IDF Regions and global projections of the number of people with diabetes (20-79 years), 2013 and 2035 Diabetes Atlas -sixth Edition: IDF 2013 Diabetes Atlas -sixth Edition: IDF 2013 Chronic complications
More informationBody Mass Index Chart = overweight; = obese; >40= extreme obesity
Pathophysiology of type 2 diabetes mellitus R. Leibel Naomi Berrie Diabetes Center 26 February 2007 Body Mass Index Chart 25-29.9 = overweight; 30-39.9= obese; >40= extreme obesity 5'0" 5'2" 5'4" Weight
More informationAtypical and Ketosis Prone Diabetes. Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas
Atypical and Ketosis Prone Diabetes Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas Atypical Diabetes in the Spectrum Classified as T1D Classified as T2D Auto-immune T1D T2D A- - KPD
More informationObese Type 2 Diabetic Model. Rat Model with Early Onset of Diabetic Complications. SDT fatty rats. SDT fatty rats
Obese Type 2 Diabetic Model rats Rat Model with Early Onset of Diabetic Complications rats Background and Origin In 24, Dr. Masuyama and Dr. Shinohara (Research Laboratories of Torii Pharmaceutical Co.,
More informationWeek 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD
Week 3, Lecture 5a Pathophysiology of Diabetes Simin Liu, MD, ScD General Model of Peptide Hormone Action Hormone Plasma Membrane Activated Nucleus Cellular Trafficking Enzymes Inhibited Receptor Effector
More informationScope. History. History. Incretins. Incretin-based Therapy and DPP-4 Inhibitors
Plasma Glucose (mg/dl) Plasma Insulin (pmol/l) Incretin-based Therapy and Inhibitors Scope Mechanism of action ผศ.ดร.นพ.ว ระเดช พ ศประเสร ฐ สาขาว ชาโภชนว ทยาคล น ก ภาคว ชาอาย รศาสตร คณะแพทยศาสตร มหาว ทยาล
More informationNormal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),
Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from
More informationDiabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:
Section #1 OBJECTIVE Diabetes Update Fall 2017 Lyle Myers BE ABLE TO DIFFERENTIATE TYPE 1 FROM TYPE 2 DIABETES Clinical features: - age at onset - body weight/bmi - family history - treatment history -
More informationSIMPLICITY IN T2DM MANAGEMENT WITH DPP4 INHIBITORS: SPECIAL POPULATION
SIMPLICITY IN T2DM MANAGEMENT WITH DPP4 INHIBITORS: SPECIAL POPULATION DR ROSE ZHAO-WEI TING ( 丁昭慧醫生 ) MBBS (HK), MRCP (UK), FHKCP, FHKAM (MEDICINE) Specialist in Endocrinology, Diabetes and Metabolism
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationDiabetes Pathophysiology and Treatment Strategies
Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Diabetes Pathophysiology and Treatment Strategies Beth Careyva MD Lehigh Valley Health Network, beth_a.careyva@lvhn.org Follow
More informationThe enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans
The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans Young Min Cho, MD, PhD Division of Endocrinology and Metabolism Seoul National University College of Medicine Plasma glucose
More informationDipeptidyl-Peptidase 4 (DPP-4) Inhibitors Drug Class Prior Authorization Protocol
Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed
More informationYiying Zhang, PhD Research Scientist. Research Summary:
Yiying Zhang, PhD Research Scientist Research Summary: Address: Naomi Berrie Diabetes Center at Columbia University Medical Center Russ Berrie Medical Science Pavilion 1150 St. Nicholas Avenue New York,
More informationMBB317. Dr D MANGNALL OBESITY. Lecture 2
MBB317 Dr D MANGNALL OBESITY Lecture 2 When the structure of the insulin receptor was first discovered it was assumed that the active beta subunit tyrosine kinase would phosphorylate some intracellular
More informationHelpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center
Helpful Hints for Taking Care of Your Diabetes Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center Objectives How big of a problem is diabetes? What is diabetes? How is
More informationPolycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in streptozotocin-induced diabetes mellitus
Chen et al. 1 Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in streptozotocin-induced diabetes mellitus Hainan Chen 1, Xueying Gu 1, I-hsin Su 2, Rita Bottino
More informationDrug Class Review Newer Diabetes Medications and Combinations
Drug Class Review Newer Diabetes Medications and Combinations Final Update 2 Report July 2016 The purpose reports is to make available information regarding the comparative clinical effectiveness and harms
More informationControl of Glucose Metabolism
Glucose Metabolism Control of Glucose Metabolism The pancreas is both an exocrine and endocrine gland. It secretes digestive enzymes into the duodenum (exocrine) and 3 specific hormones into the bloodstream
More informationGLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION.
GLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION. Patricia Garnica MS, ANP-BC, CDE, CDTC Inpatient Diabetes Nurse Practitioner North
More informationla prise en charge du diabète de
N21 XIII Congrès National de Diabétologie, 29 mai 2011, Alger Intérêt et place des Anti DPP4 dans la prise en charge du diabète de type 2 Nicolas PAQUOT, MD, PhD CHU Sart-Tilman, Université de Liège Belgique
More informationR. Leibel Naomi Berrie Diabetes Center 19 March 2010
Pathophysiology of type 2 diabetes mellitus R. Leibel Naomi Berrie Diabetes Center 19 March 2010 Body Mass Index Chart 25-29.9 29.9 = overweight; 30-39.9= 39.9 obese; >40= extreme obesity 5'0" 5'2" 52
More informationDipeptidyl peptidase 4 inhibitor linagliptin can decrease the dosage of erythropoiesisstimulating
Aono and Sato Renal Replacement Therapy (2016) 2:44 DOI 10.1186/s41100-016-0058-7 RESEARCH Open Access Dipeptidyl peptidase 4 inhibitor linagliptin can decrease the dosage of erythropoiesisstimulating
More informationMetabolic and Cardiovascular Disease Models and Services MODELS AND SERVICES DESIGNED TO TAKE YOUR STUDY FURTHER
Metabolic and Cardiovascular Disease Models and Services MODELS AND SERVICES DESIGNED TO TAKE YOUR STUDY FURTHER Metabolic and Cardiovascular Disease Models and Services Diabetes, hypertension, heart disease
More informationIndividualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD
Individualizing Type 2 Diabetes Management Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Harsh Statistics 30.3 million (9.4% of population) in US had DM in 2015 The percent of population with DM increases
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION doi:10.1038/nature11464 Supplemental Figure S1. The expression of Vegfb is increased in obese and diabetic mice as compared to lean mice. a-b, Body weight and postprandial blood
More informationWhat systems are involved in homeostatic regulation (give an example)?
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview
More informationTargeting simultaneously GLP-1, GIP and glucagon receptors : a new paradigm for treating obesity and diabetes
SHORT COMMENT FOR NATURE REVIEWS ENDOCRINOLOGY Targeting simultaneously GLP-1, GIP and glucagon receptors : a new paradigm for treating obesity and diabetes André J. SCHEEN (1), Nicolas PAQUOT (2) (1)
More informationImportance of Nutrition
The EAT WELL Plate Canada s food guide Food pyramid Importance of Nutrition Energy for body metabolism (nerve impulses, contraction of muscles, repair and replacement of cells Raw materials for building
More informationJournal Club WS 2012/13 Stefanie Nickl
Journal Club WS 2012/13 Stefanie Nickl Background Mesenchymal Stem Cells First isolation from bone marrow 30 ys ago Isolation from: spleen, heart, skeletal muscle, synovium, amniotic fluid, dental pulp,
More information효과적인경구혈당강하제의조합은? 대한당뇨병학회제 17 차연수강좌 ( ) 가천의대길병원내분비대사내과
효과적인경구혈당강하제의조합은? 대한당뇨병학회제 17 차연수강좌 (2011.10.30.) 가천의대길병원내분비대사내과 박이병 내용 배경 경구혈당강하제의병합이왜필요한가? (WHY?) 경구혈당강하제의병합은언제시작하나? (WHEN?) 경구혈당강하제의병합은어떻게하는것이좋은가?(HOW) 맺음말 배경 : drugs for treating diabetes In 1995 :
More informationDIABETES RESEARCH A CLINICIAN S OVERVIEW
DIABETES RESEARCH 2012- A CLINICIAN S OVERVIEW Alan B. Cortez, MD Chief, Pediatrics Pediatric Endocrinology Kaiser-Permanente Orange County January 21, 2012 Research Overview Biotechnology Treatment Pharmaceutical
More informationWorkshop. Factors influencing food intake? How decrease food choice related morbidity/mortality
Workshop Factors influencing food intake? How decrease food choice related morbidity/mortality Modifiable behavioral traits? Strength /weakness Limits to success of interventions? Describe current research
More informationInsulin resistance and pancreatic b cell failure
Review series introduction Insulin resistance and pancreatic b cell failure Masato Kasuga Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. It is now
More informationEat Healthy. Learn How to Read Food Labels
Chapter 6 Learn How to Read Food Labels You Will Learn About: The different types of nutrition information on a food label 1. Ingredient List 2. Nutrition Facts Panel 3. Nutrient Claims Diabetes, Exercise
More informationNew Paradigms of Type 2 Diabetes. From:
New Paradigms of Type 2 Diabetes From: www.nusi.org Presenter Disclosure Presenters Jason Fung Relationships with commercial interests: Grants/Research Support: None Grants/Speakers Bureau/Honoraria: Consulting
More informationThe Atoms of Life. What are other elements would you expect to be on this list? Carbon Hydrogen Nitrogen Oxygen Phosphorous Sulfur (sometimes)
Macromolecules The Atoms of Life The most frequently found atoms in the body are Carbon Hydrogen Nitrogen Oxygen Phosphorous Sulfur (sometimes) What are other elements would you expect to be on this list?
More informationΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ
ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΘΩΜΑΣ ΠΑΠΑΔΟΠΟΥΛΟΣ, MD, PHD ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΙΑΤΡΙΚΟ ΔΙΑΒΑΛΚΑΝΙΚΟ ΚΕΝΤΡΟ Inflammation as a cause of disease has entered the popular imagination. Diet ( macronutrients )
More informationMOA: Long acting glucagon-like peptide 1 receptor agonist
Alexandria Rydz MOA: Long acting glucagon-like peptide 1 receptor agonist Increases glucose dependent insulin secretion Decreases inappropriate glucagon secretion Increases β- cell growth and replication
More informationBIOM2010 (till mid sem) Endocrinology. e.g. anterior pituitary gland, thyroid, adrenal. Pineal Heart GI Female
BIOM2010 (till mid sem) Endocrinology Endocrine system Endocrine gland : a that acts by directly into the which then to other parts of the body to act on (cells, tissues, organs) : found at e.g. anterior
More informationWayne Gravois, MD August 6, 2017
Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion
More informationMetabolism of medium and long chain triglycerides Role on energy balance. Hormone/Food intake pilot data
Medium Chain Triglycerides & Energy Balance Marie-Pierre St-Onge, Ph.D, FAHA New York Obesity Nutrition Research Center Columbia University Outline Metabolism of medium and long chain triglycerides Role
More informationNewer Drugs in the Management of Type 2 Diabetes Mellitus
Newer Drugs in the Management of Type 2 Diabetes Mellitus Dr. C. Dinesh M. Naidu Professor of Pharmacology, Kamineni Institute of Medical Sciences, Narketpally. 1 Presentation Outline Introduction Pathogenesis
More informationGut hormones KHATTAB
Gut hormones PROF:ABD ALHAFIZ HASSAN KHATTAB Gut as an endocrine gland The talk will cover the following : Historical background. Why this subject is chosen. Gastro-intestinal hormones and their function.
More informationDespite vigorous research aimed at combating type
n reports n Examining the Mechanisms of Glucose Regulation Curtis L. Triplitt, PharmD, CDE Abstract The prevalence of diabetes mellitus (DM) increased by 49% between 1990 and 2000, reaching nearly epidemic
More informationTaking Translation into the Clinic: Can We Improve the Probability of Success?
Taking Translation into the Clinic: Can We Improve the Probability of Success? Janssen R&D/Cardiovascular & Metabolism Therapeutic Area Nicholas Di Prospero, MD, PhD Translational Medicine Group Disclaimer:
More informationFOR REVIEW. BMB Reports - Manuscript Submission. Manuscript Draft. Manuscript Number: BMB
BMB Reports - Manuscript Submission Manuscript Draft Manuscript Number: BMB-18-095 Title: Insulin Receptor Substrate 2:A Bridge between Hippo and AKT Pathways Article Type: Perspective (Invited Only) Keywords:
More informationUnmasking the evidence of efficacy and safety. Cheaper or Better DEBATE (pros) Panagiotis Halvatsiotis
Unmasking the evidence of efficacy and safety. Cheaper or Better DEBATE (pros) Panagiotis Halvatsiotis 2 nd Department of Internal Medicine Research Unit & Diabetes Center of Athens University Medical
More informationWhat s New in Diabetes Treatment. Disclosures
What s New in Diabetes Treatment Shiri Levy M.D. Henry Ford Hospital Senior Staff Physician Service Chief, West Bloomfield Hospital Endocrinology, Metabolism, Bone and Mineral Disorders Disclosures None
More informationHOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis
HOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis My personal objective: identification of biomarkers of (optimal) health Biomarker Definition: a characteristic that is objectively measured and evaluated
More informationEB Education Revision Guide. How to work with Homeostasis: Part 2 Blood Glucose Regulation
EB Education Revision Guide How to work with Homeostasis: Part 2 Blood Glucose Regulation Blood Glucose Regulation a) Why your body regulates glucose levels What you need to know about Homeostasis: Part
More information